1.

Opportunistic screening for atrial fibrillation using a photoplethysmography technique in geriatric patients, a preliminary analysis of the Dutch-GERAF Study

1.

Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiolog...

1.

Health technology assessment on catheter ablation of atrial fibrillation in Belgium

1.

Crystal Clots as Therapeutic Target in Cholesterol Crystal Embolism.

1.

A41-2 The Belgian Odissea Mission: Changes in heart rate variability during and after space flight

2.

A41-2 The Belgian Odissea Mission: Changes in heart rate variability during and after space flight

3.

A41-2 The Belgian Odissea Mission: Changes in heart rate variability during and after space flight

1.

136-15: First Belgian experience with the Endoscopic laser balloon Ablation System for pulmonary vein isolation – 1 year follow-up

1.

The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study

1.

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium

1.

Baseline demographics of a contemporary Belgian atrial fibrillation cohort included in a large randomised clinical trial on targeted education and integrated care (AF-EduCare/AF-Ed...

2.

Baseline demographics of a contemporary Belgian atrial fibrillation cohort included in a large randomised clinical trial on targeted education and integrated care (AF-EduCare/AF-Ed...

3.

Baseline demographics of a contemporary Belgian atrial fibrillation cohort included in a large randomised clinical trial on targeted education and integrated care (AF-EduCare/AF-Ed...

1.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

2.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

3.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

4.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

5.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

6.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.

7.

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.